Literature DB >> 17923698

Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse.

Emanuele Giurisato1, Marina Cella, Toshiyuki Takai, Tomohiro Kurosaki, Yungfeng Feng, Gregory D Longmore, Marco Colonna, Andrey S Shaw.   

Abstract

The receptor NKG2D allows natural killer (NK) cells to detect virally infected, stressed, and tumor cells. In human cells, NKG2D signaling is mediated through the associated DAP10 adapter. Here we show that engagement of NKG2D by itself is sufficient to stimulate the formation of the NK immunological synapse (NKIS), with recruitment of NKG2D to the center synapse. Mutagenesis studies of DAP10 revealed that the phosphatidylinositol 3-kinase binding site, but not the Grb2 binding site, was required and sufficient for recruitment of DAP10 to the NKIS. Surprisingly, we found that in the absence of the Grb2 binding site, Grb2 was still recruited to the NKIS. Since the recruitment of Grb2 was dependent on phosphatidylinositol-(3,4,5)-trisphosphate (PIP3), we explored the possibility that recruitment to the NKIS is mediated by a pleckstrin homology (PH) domain-containing binding partner for Grb2. We found that the PH domain of SOS1, but not that of Vav1, was able to be recruited by PIP3. These results provide new insights into the mechanism of immunological synapse formation and also demonstrate how multiple mechanisms can be used to recruit the same signaling proteins to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923698      PMCID: PMC2169389          DOI: 10.1128/MCB.01477-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

Review 1.  Paired inhibitory and activating receptor signals.

Authors:  L S Taylor; S P Paul; D W McVicar
Journal:  Rev Immunogenet       Date:  2000

2.  Imaging synapse formation during thymocyte selection: inability of CD3zeta to form a stable central accumulation during negative selection.

Authors:  Lauren I Richie; Peter J R Ebert; Lawren C Wu; Matthew F Krummel; John J T Owen; Mark M Davis
Journal:  Immunity       Date:  2002-04       Impact factor: 31.745

3.  A monomeric red fluorescent protein.

Authors:  Robert E Campbell; Oded Tour; Amy E Palmer; Paul A Steinbach; Geoffrey S Baird; David A Zacharias; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

Review 4.  The two hats of SOS.

Authors:  Anjaruwee Nimnual; Dafna Bar-Sagi
Journal:  Sci STKE       Date:  2002-08-13

Review 5.  Assembly of the immunological synapse for T cells and NK cells.

Authors:  Daniel M Davis
Journal:  Trends Immunol       Date:  2002-07       Impact factor: 16.687

6.  The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor.

Authors:  Stephan Gasser; Sandra Orsulic; Eric J Brown; David H Raulet
Journal:  Nature       Date:  2005-07-03       Impact factor: 49.962

7.  Solution structure of N-terminal SH3 domain of Vav and the recognition site for Grb2 C-terminal SH3 domain.

Authors:  Kenji Ogura; Koji Nagata; Masataka Horiuchi; Etsuko Ebisui; Tomoyo Hasuda; Satoru Yuzawa; Motohiko Nishida; Hideki Hatanaka; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2002-01       Impact factor: 2.835

8.  Novel recognition mode between Vav and Grb2 SH3 domains.

Authors:  M Nishida; K Nagata; Y Hachimori; M Horiuchi; K Ogura; V Mandiyan; J Schlessinger; F Inagaki
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

Review 9.  Tumor cell recognition by natural killer cells.

Authors:  Eric O Long
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

10.  UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.

Authors:  Claire L Sutherland; N Jan Chalupny; Kenneth Schooley; Tim VandenBos; Marek Kubin; David Cosman
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

View more
  22 in total

Review 1.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Cancer Immunol Res       Date:  2014-11       Impact factor: 11.151

2.  Stage-specific requirement of kinase PDK1 for NK cells development and activation.

Authors:  Junming He; Yuande Wang; Tian Liu; Guangao Liu; Shasha Chen; Qiaozhen Li; Yuhe Quan; Haoyan Yang; Jin Feng; Song Wang; Meixiang Yang; Zhongjun Dong
Journal:  Cell Death Differ       Date:  2019-01-08       Impact factor: 15.828

Review 3.  Line of attack: NK cell specificity and integration of signals.

Authors:  Yenan T Bryceson; Eric O Long
Journal:  Curr Opin Immunol       Date:  2008-04-23       Impact factor: 7.486

Review 4.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

Review 5.  Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma.

Authors:  Jian Wang; Cun-Di Li; Lin Sun
Journal:  Biomolecules       Date:  2020-02-14

6.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

Review 7.  Natural killer cell responses to viral infection.

Authors:  Joshua D Brandstadter; Yiping Yang
Journal:  J Innate Immun       Date:  2011-03-12       Impact factor: 7.349

Review 8.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

9.  NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion.

Authors:  Ilaria Tassi; Marina Cella; Rachel Presti; Angela Colucci; Susan Gilfillan; Dan R Littman; Marco Colonna
Journal:  Blood       Date:  2008-09-10       Impact factor: 22.113

10.  PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion.

Authors:  Colin M Segovis; Renee A Schoon; Christopher J Dick; Lucas P Nacusi; Paul J Leibson; Daniel D Billadeau
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.